Message from Vystar: Ingredient Branding: A Successful Strategy to Grow Your Brands, Sales and Profits
The companies behind these products promote the ingredients to provide added value and enhance the image and quality of the host brand. This marketing strategy is called "ingredient branding."
Vystar® Corporation has created a robust ingredient branding program designed to support you in growing your brands and selling products made with Vytex® Natural Rubber Latex (NRL). A key component of our program is Vystar Professional SupportSM (VPS), which enhances your brand by providing a broad menu of technical, regulatory and marketing support options tailored to your specific needs. Vystar is the only supplier of natural rubber latex offering this higher level of support for our customers.
Vytex NRL is well positioned to be the value-added ingredient for many latex-based products. Its ultra low protein, reduced non-rubber formulation provides numerous end-user benefits as well as production enhancements and cost savings potential for the manufacturer.
Technical
Our global team of scientists, technical advisors and manufacturing specialists can provide technical expertise to address diverse customer needs, ranging from initial evaluation and trials to full integration and commercialization. We continually invest in the future of Vytex NRL as the industry standard for natural rubber latex through ongoing research and development and rigorous testing.
Regulatory and intellectual property (IP)
Navigating the complex regulatory environment for medical device clearances can be challenging. Our experienced team offers regulatory and IP support to manufacturers branding with Vytex NRL, making the regulatory path easier and creating asset value through sound IP licensing practices. With more than 20 years of regulatory experience in the healthcare and technology sectors, we can assist with testing, claims, filings and reporting for new medical device clearances and approvals, including U.S. Food and Drug Administration's 510(k) and Europe's Medical Device Directive (MDD).